## Products

# Names and compounds of our products

Lundbeck has a broad range of products within brain diseases. With registered products in more than 80 countries, we leverage our global presence to bring innovative therapies to people living with brain diseases around the world.

# Neurological disorders

| Disease Area          | Trademark                                                  | Compound     | First Registration | Registered no. of Countries |  |
|----------------------|-----------------------------------------------------------|--------------|--------------------|------------------------------|--|
| Parkinson's disease   | Azilect®                                                 | Rasagiline   | 2005               | 7                            |  |
| Alcohol dependence    | Selincro®                                                | Nalmefene    | 2013               | 37                           |  |
| Alzheimer's disease   | Ebixa®, Ebix®, Abixa®, Memantine Merz®                  | Memantine    | 2002               | 76                           |  |
| Migraine              | Vyepti®                                                  | Eptinezumab   | 2020               | 52                           |  |
| Epilepsy             | Sabril®                                                  | Vigabatrin   | 1993               | 2                            |  |
|                      | Onfi®, Frisium®                                         | Clobazam     | 1975               | 2                            |  |

# Psychiatric disorders

| Disease Area                   | Trademark                                                                                      | Compound                 | First Registration | Registered no. of Countries |  |
|--------------------------------|-----------------------------------------------------------------------------------------------|--------------------------|--------------------|------------------------------|--|
| Depression, Anxiety              | Rexulti®, Rxulti®                                                                        | Brexpiprazole            | 2015               | 62                           |  |
|                                | Brintellix®, Trintellix®, Fonksera®, Vortioson®, Vurtuoso®                             | Vortioxetine             | 2013               | 95                           |  |
|                                | Cipralex®, Lexapro®, Sipralexa®, Seroplex®, Entact®, Lepax®, Premalex®, Prilect®, Esipram®, Esertia®, Rhea Escitalopram® | Escitalopram Oxalate     | 2001               | 100                          |  |
|                                | Cipramil®, Seropram®, Cipram®, Sepram®, Celexa®, Elopram®, Prisdal®                     | Citalopram               | 1988               | 60                           |  |
|                                | Deanxit®                                                                                  | Flupentixol + melitracene| 1971               | 19                           |  |
|                                | Noritren®, Nortrilen®, Sensaval®                                                          | Nortriptyline            | 1963               | 14                           |  |
|                                | Saroten®, Sarotex®, Redomex®, Sarotena®                                                  | Amitriptyline            | 1960               | 9                            |  |
| Psychosis                      | Rexulti®, Rxulti®                                                                        | Brexpiprazole            | 2015               | 62                           |  |
|                                | Abilify Maintena®                                                                         | Aripiprazole             | 2013               | 50                           |  |
|                                | Serdolect®                                                                                 | Sertindol                | 1996               | 30                           |  |
|                                | Cisordinol®, Clopixol®, Ciatyl-Z®                                                        | Zuclopenthixol           | 1982               | 55                           |  |
|                                | Cisordinol Depot®, Clopixol Depot®, Ciatyl-Z Depot®                                       | Zuclopenthixoldecanoate  | 1976               | 74                           |  |
|                                | Fluanxol Depot®, Depixol®, Fluanxol LP®, Fluanxol Retard®                               | Cis(Z)-Flupenticoldecanoate | 1970           | 67                           |  |
|                                | Fluanxol®, Fluanxol Mite®, Depixol®                                                        | Flupentixol              | 1965               | 43                           |  |
|                                | Truxal®                                                                                   | Chlorprothixene          | 1959               | 16                           |  |
|                                | Cisordinol-Acutard®, Clopixol-Acutard®, Clopixol-Acuphase®, Ciatyl-Z-Acuphase®        | Zuclopenthixolacetate    | 1986               | 65                           |  |

# Other diseases

| Disease Area | Trademark   | Compound   | First Registration | Registered no. of Countries |  |
|--------------|-------------|------------|--------------------|------------------------------|--|
| Other        | Northera®   | Droxidopa  | 2014               | 1                            |  |

### Side effects

Reporting of potential side effects is important in order for us to continuously evaluate the benefits and risks of our products and take proactive action as warranted.

[Report a side effect here](/content/global/report-adverse-drug-reaction/index.html)

More from Lundbeck

**Research and development**  
R&D of new and improved treatments is at the core of what we do.

[Learn more](/content/global/our-science/research-and-development/index.html)

**Patients**  
We see patients as people and are committed to support the person behind.

[Learn more](/content/global/patients/index.html)

**Pipeline**  
Discover our projects and compounds in development.

[Learn more](/content/global/our-science/pipeline/index.html)